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Abstract A phosphorylatable protein band of about 94 kDa (as
judged by SDS^PAGE) which co-purifies and co-immunopreci-
pitates with Golgi apparatus casein kinase (G-CK) from rat
lactating mammary gland has been shown by mass spectrometric
sequence analysis to be identical or very similar to the glucose-
regulated protein, GRP94. GRP94 is also readily phosphorylated
by G-CK (Km = 0.2 WM) at seryl sites which are different from
the sites affected by casein kinase-2 (CK2) in the same protein. A
study with peptide substrates would indicate that the G-CK sites
in GRP94 conform to the motif S-R/K-E-X (X being different
from D and E) which is not recognized by CK2.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Most Ser/Thr protein kinases recognize sites speci¢ed by
basic and/or prolyl residues. In contrast, few of them are
acidophilic in nature in that their consensus sequences rely
on carboxylic and/or previously phosphorylated side chains
acting as speci¢city determinants [1]. Often, these acidophilic
protein kinases are referred to with the conventional term
‘casein kinases’ as they share the ability to phosphorylate
casein in vitro. In some instances, this feature does not re£ect
any physiological role in casein phosphorylation: thus type 1
and type 2 ‘casein kinases’ (recently re-named as protein ki-
nases CK1 and CK2) are ubiquitous and pleiotropic enzymes
totally unrelated to casein [2^5].
In contrast, bona ¢de casein kinase activity is present in the
Golgi apparatus of lactating mammary gland, where it is com-
mitted to the phosphorylation of casein fractions prior to their
secretion with milk. Despite the fact that this Golgi apparatus
casein kinase (G-CK, also previously termed GEF-CK, ‘Gol-
gi-enriched fraction casein kinase’) has been known for a long
time (e.g. [6,7]), its primary structure is still undeciphered.
Little information is available about its biochemical proper-
ties, except for its site speci¢city which has been thoroughly
investigated using casein fractions and synthetic peptides as
phosphorylatable substrates [8^11]. These studies showed that
the G-CK consensus is crucially dependent on a glutamic acid
(or a previously phosphorylated serine) at position n+2 rela-
tive to the target amino acid, generating the motif S-X-E/Sp,
which is similar to, but de¢nitely distinct from the minimum
consensus of CK2, S/T-X-X-E/D/Sp/Yp [11,12].
Based on these di¡erences in speci¢city, a highly selective
peptide substrate has been developed [11], which allowed the
detection of G-CK not only in mammary gland, but also in
the Golgi apparatus of a variety of tissues [13] where its casein
kinase activity would otherwise be masked by predominant
activity of CK1 and CK2. This ¢nding raised the possibility
that several proteins already known to contain phosphorylat-
ed S-X-E motifs in sequences not suited for other classes of
ubiquitous ‘casein kinases’, with special reference to highly
pleiotropic CK2, might be natural substrates of G-CK. This
of course would especially apply to proteins either secreted
from the cell or anyway functionally connected to the Golgi
apparatus, where G-CK appears to be speci¢cally located [13].
The list of such putative substrates of G-CK is quite long,
including, among others, ¢brinogen, ovalbumin, pepsinogen,
ACTH, furin, osteopontin, matrix Gla protein and mannose-
6-P receptor (see [13,14] and references therein), but only
sporadically, notably in the case of osteopontin [15], was the
ability of G-CK to catalyze the postulated phosphorylation
demonstrated.
Here, we show that, in an attempt to purify G-CK to
homogeneity from rat lactating mammary gland, a phospho-
protein co-elutes with the kinase activity throughout all the
puri¢cation steps. This protein turns out to be very similar if
not identical to glucose-regulated protein-94 (GRP94), be-
longing to the stress protein family, and to undergo phosphor-
ylation by G-CK at sites di¡erent from those a¡ected by CK2.
2. Materials and methods
2.1. Chemicals, biochemicals and peptides
[Q-32P]ATP, enhanced chemiluminescence detection system and sec-
ondary antibodies were purchased from Amersham (Arlington
Heights, USA), anti-GRP94 antibodies were from Stress-Gen Biotech-
nologies Corp. (Victoria, B.C., Canada) and the other chemicals were
from Sigma Chemical Company (Dorset, UK). Anti-p-£uorosulfonyl-
benzoyl 5P-adenosine (FSBA) antibodies were kindly provided by Dr.
P.J. Parker (London, UK). GRP94-derived peptides were synthesized
by solid phase peptide synthesis [16] on a 4-hydroxymethyl-phenox-
ymethylcopolystirene^1% divinylbenzene resin (Perkin Elmer) using a
peptide synthesizer (Model 431-A, Applied Biosystems) according to
the manufacturer’s protocol.
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The purity of crude peptides was 85% or more on the basis of peak
areas as determined by analytical HPLC. The molecular weights
checked with a KRATOS MALDI-TOF MS (Shimadzu) agreed
well with the theoretical values.
2.2. Protein kinases
G-CK was routinely puri¢ed from the lactating mammary gland of
10 rats. The Golgi apparatus was isolated as detailed elsewhere
[13,17].
The purity of the Golgi fraction was documented by its high gal-
actosyl transferase activity (v270 nmol/h/mg) as opposed to undetect-
able NADH^cytochrome c reductase and glucose-6-phosphatase ac-
tivities. Extraction of G-CK from the particulate fraction was
performed as described previously [13]. The soluble extract was sub-
jected to three puri¢cation steps as outlined in Fig. 1A. The chroma-
tography through DEAE-Sepharose and Heparin-Sepharose columns
was performed as described previously [13]. The peak of G-CK activ-
ity, eluted from Heparin-Sepharose at 0.5 M NaCl, was then chroma-
tographed through a FPLC-Superdex 200 column (10 mmU300 mm),
equilibrated with bu¡er A (20 mM Tris^HCl pH 7.5, 5 mM magne-
sium acetate, 1 mM EGTA, 10 mM 2-mercaptoethanol, 0.1% Triton
X-100, 10% glycerol, 0.05 mM phenylmethylsulfonyl £uoride (PMSF),
0.02% NaN3) containing 500 mM NaCl. 0.2 ml fractions were col-
lected at a £ow rate of 0.4 ml/min. At this stage, G-CK, eluted as a
broad peak of activity displaying an apparent Mr of 400 kDa (Fig.
1B), was still heavily contaminated by a 94 kDa band subsequently
identi¢ed as GRP94 (see inset Fig. 1B). To remove GRP94, G-CK
was passed through a ConA-Sepharose column (5 ml), equilibrated
with bu¡er B (20 mM Tris^HCl pH 7.5, 1 mM MnCl2, 1 mM CaCl2,
10 mM 2-mercaptoethanol, 10% glycerol, 0.05 mM PMSF); G-CK
activity was eluted in the £owthrough, while GRP94 was retained on
the column and subsequently eluted with bu¡er B containing 0.6 M K-
D-methylmannoside.
Puri¢cation of rat liver CK2 was performed essentially as described
elsewhere [18].
2.3. Reaction with FSBA
The G-CK fraction eluted from DEAE-Sepharose (10 Wg) was in-
cubated either alone or with 0.5 mM FSBA and 10 mM MnCl2, in the
absence or presence of 2 mM ATP at 30‡C for 1 h [19]. Reacted
proteins were resolved by 8% SDS^PAGE, transferred onto nitrocel-
lulose and immunostained with anti-FSBA antibody at a dilution of
1:500.
2.4. In-gel phosphorylation assay
G-CK from DEAE-Sepharose (50 Wg) was subjected to SDS^PAGE
followed by in situ denaturation/renaturation [20]. After renaturation,
the membrane was incubated for 30 min at 30‡C in a bu¡er contain-
ing 50 mM Tris^HCl, 10 mM MnCl2, 50 WM [Q-32P]ATP (3000^6000
Ci/mmol). The membrane was washed twice for 10 min in 30 mM
Tris^HCl (pH 7.5), once in 0.1% NP-40 and once more in 30 mM
Tris^HCl (pH 7.5). The radioactivity incorporated was detected by
Instant Imager (Packard).
2.5. Microsequencing
15 Wg of the G-CK containing fraction, eluted from Superdex 200,
was subjected to SDS^PAGE and 170 and 94 kDa bands were iden-
ti¢ed by Coomassie staining. The two bands were then excised, de-
stained and tryptically digested as described elsewhere [21]. The solu-
tion containing the tryptic fragments was then electrosprayed into a
Finnigan LCQ ion trap. Peptides of interest were isolated by trapping
and then fragmented. The ions were labeled according to Roepstor¡
[22]. The resulting MS/MS spectra were either manually interpreted or
used for database searching using the Sequest program. The MS/MS
spectrum of one of the peptides is shown in Fig. 3 together with its
interpretation. The rest of the sequences are indicated in Section 3.
2.6. Puri¢cation of GRP94 from rat liver microsomes
The microsomal fraction was extracted, as previously described [13],
and subjected to a DEAE-Sepharose followed by a Heparin-Sephar-
ose column as previously described [13]. The eluted fractions were
collected and assayed for immunoreactivity against anti-GRP94.
The GRP94 peak, eluted from Heparin-Sepharose at 0.5 M NaCl,
was chromatographed on FPLC-Superdex 200 (10 mmU300 mm),
previously equilibrated with bu¡er A containing 500 mM NaCl.
0.2 ml fractions were collected at a £ow rate of 0.4 ml/min. The im-
munoreactive peak with an apparent Mr of 200 kDa was passed
through a ConA-Sepharose column (5 ml), equilibrated with bu¡er
B. GRP94 was eluted with bu¡er B containing 0.6 M K-D-methylman-
noside. The ¢nal preparation was free of any kind of ‘casein kinase’
activity as also judged by using peptide substrates speci¢c for CK1,
CK2 and G-CK.
2.7. Phosphorylation assays
Phosphorylation of GRP94 (250 nM) by G-CK (50 ng) was per-
formed at 30‡C in 40 Wl of an incubation mixture containing 50 mM
Tris^HCl pH 7.5, 10 mM MnCl2, 50 WM [Q-32P]ATP (speci¢c activity
1500 cpm/pmol) and 0.1 WM polylysine. When the phosphorylating
kinase was CK2 (200 ng), MnCl2 was replaced by 10 mM MgCl2 and
150 mM NaCl was also added to the incubation medium. At the end
of incubation (10 min), the samples were subjected to 8% SDS^PAGE
and the radioactive bands were detected and quanti¢ed by means of
Instant Imager (Packard). Phosphorylation of peptides and kinetic
analyses were performed as in [13], except for the omission of MgCl2
from the incubation medium. For routine assay of G-CK, the speci¢c
L-casein-derived peptide substrate L(28^40) [11] was used as phos-
phate acceptor.
2.8. Immunoprecipitation
Either Golgi fraction (200 Wg) or G-CK puri¢ed after ConA-Se-
pharose treatment (5 Wg) or GRP94 (1 Wg) were pre-cleared by incu-
bation with protein A-Sepharose for 45 min at 4‡C. Subsequently, the
samples were incubated overnight at 4‡C with anti-GRP94. The im-
munocomplexes were analyzed for G-CK activity by incubation with
the speci¢c peptide substrate L(28^40) and [Q-32P]ATP as described
above, and for the presence of GRP94 by Western blotting using
anti-antibody at a 1:500 dilution.
2.9. Phosphoamino acid analysis
GRP94, phosphoradiolabeled after incubation with either G-CK or
CK2 and [Q-32P]ATP, was resolved by SDS^PAGE. The protein was
electrophoretically transferred onto a nitrocellulose ¢lter and radio-
labeled GRP94 was localized by autoradiography. The excised band
was tryptically digested and then hydrolyzed with 6 M HCl hydrolysis
at 110‡C for 4 h. Radiolabeled phosphoamino acids were isolated by
pH 1.9 high-voltage paper electrophoresis and evidenced by autora-
diography [23].
3. Results
A summary of the puri¢cation steps of G-CK is provided in
Fig. 1A. The activity was monitored by using the speci¢c
peptide substrate, KKKIEKFQSEEQQQ, which is not af-
fected by other ‘casein kinases’ [13]. During the ¢nal puri¢ca-
tion step on Superdex 200, G-CK activity was eluted as a
broad symmetric peak of apparent Mr around 400 kDa
(Fig. 1B). As shown in the inset of Fig. 1B, the pro¢le of
G-CK activity was paralleled by the appearance of two phos-
phoradiolabeled bands of about 170 and 94 kDa, respectively,
if the eluted fractions were incubated with [Q-32P]ATP and
Mg2. Both bands were also detectable by anti-FSBA immu-
nostaining but only the 170 kDa band was detectable by in-gel
autophosphorylation, suggesting that it might be the kinase
itself (Fig. 2). Attempts to obtain sequence information from
it failed due to very low fragmentation yield; one fragment
however, GDXXXXDFGXXR, displayed the highly con-
served DFG motif found in protein kinase domain VII.
In contrast, the 94 kDa band yielded ¢ve tryptic fragments,
which were analyzed by MS/MS spectra (one of which is
shown as an example in Fig. 3). All of the sequences obtained
(EEEAIQLDGLNASQIR; GTTITLVKEEASDYLELDTIK;
EFEPLLNWMK; SILFVPTSAPR; VFITDDFHDMMPK)
matched that of mouse GRP94.
It can therefore be concluded that the 94 kDa phosphory-
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latable protein associated with G-CK throughout all the pu-
ri¢cation steps is GRP94 or a very closely related protein.
Tight interaction between G-CK and GRP94 has been con-
¢rmed by immunoprecipitating GRP94 from the extract of
mammary gland Golgi apparatus with anti-GRP94 antibodies
and by showing that signi¢cant amounts of G-CK activity, as
judged from the speci¢c peptide phosphorylation, are present
in the immunoprecipitate (Fig. 4).
Once established that GRP94 is associated with G-CK, we
wanted to assess if its phosphorylation was actually mediated
by G-CK itself. GRP94 is known to be a substrate of another
‘casein kinase’, CK2 [24], which however is hardly detectable
in the Golgi apparatus [13]. To compare the abilities of G-CK
and CK2 to phosphorylate GRP94, this latter was puri¢ed
free of G-CK from rat liver microsomes and subjected to in
vitro phosphorylation assays in the presence of either G-CK
(rendered free of GRP94 by ConA-Sepharose treatment as
described in Section 2.2) or CK2. As shown in Fig. 5, no
signi¢cant autophosphorylation of GRP94 could be detected,
at variance with a previous report [25]. Instead, GRP94 was
readily phosphorylated by either G-CK or CK2 (Fig. 5).
The phosphorylation stoichiometry approached, with both
kinases, 1 mol P/mol (not shown); however, the kinetic con-
stants and, even more, the SerP/ThrP ratio were quite di¡er-
ent. GRP94 displayed higher a⁄nity for G-CK as compared
to CK2 (Km values 0.20 vs. 0.50 WM), and the latter prefer-
entially phosphorylates threonyl residues, whereas only seryl
residues were a¡ected by G-CK (see Fig. 5), in agreement with
Fig. 2. Anti-FSBA immunoreactivity and in-gel autophosphorylation
of G-CK. The experiments were performed using 30 Wg of G-CK
preparation eluted from DEAE-Sepharose. A: anti-FSBA immuno-
reactivity. Lane 1, G-CK alone; lanes 2 and 3, G-CK in the pres-
ence of FSBA (0.5 mM) either alone or in the presence of 2 mM
ATP. B: autoradiography of phosphorylation assay following in
situ denaturation/renaturation of G-CK (see Section 2).
Fig. 3. MS/MS analysis of tryptic digestion of GRP94. The ¢gure
shows the MS/MS spectrum obtained from 2+ peptide ion m/z
894.0 in the ion trap mass spectrometer. For details, see Section 2.
Fig. 1. Puri¢cation of G-CK. A synopsis of the puri¢cation procedure of G-CK from soluble extract of Golgi-enriched fraction is shown in A.
B shows the pro¢le of G-CK activity eluted from Superdex 200. The inset refers to the autophosphorylation of individual fractions (as indi-
cated) subjected to SDS^PAGE and autoradiography. The experimental conditions for gel ¢ltration, protein kinase assay and autophosphoryla-
tion are detailed in Section 2.
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the notion that threonine is not a good target for G-CK
[1,11]. The phosphorylation of threonyl residues by CK2 did
not come as a surprise either, since the main radiolabeled
peptide from GRP94 phosphorylated by CK2 corresponded
to a C-terminal segment of GRP94 including four threonines,
all displaying the CK2 consensus sequence [24]. Five consen-
sus sequences for G-CK (S-X-E) are found in GRP94, namely
S-17, S-326, S-342, S-426 and S-586. Curiously, all these po-
tential sites conform to the motif S-R/K-E, with a basic res-
idue inserted between the phosphoacceptor residue and the
acidic determinant at position n+2. This feature would be
detrimental to CK2 phosphorylation [1], while it is well tol-
erated by G-CK (unpublished data). All ¢ve tridecapeptides
reproducing the putative G-CK sites were phosphorylated by
G-CK albeit with di¡erent e⁄ciencies (Table 1); in contrast,
none of them was phosphorylated by CK2 to any appreciable
extent (not shown). It is quite likely therefore that one or
more of these residues are also the one(s) which are phosphor-
ylated by G-CK in full length GRP94.
4. Discussion
The work described here adds a new member to the still
short but growing list of substrates of the G-CK. For a long
time, G-CK was believed to be a highly dedicated kinase,
speci¢cally committed just to the phosphorylation of casein
fractions within lactating mammary gland. Recently however,
using a highly selective peptide substrate instead of casein, G-
CK was also detected in the Golgi apparatus of a variety of
tissues where casein is not present [13], disclosing the possi-
bility that a number of phosphoproteins known to contain the
phosphorylated motif Sp-X-E, identical to the one recognized
by G-CK, might be targets of this enzyme. While the list of
these putative G-CK substrates is quite long, including among
Fig. 4. Co-immunoprecipitation of G-CK with GRP94 from Golgi
extracts. Anti-GRP94 immunoprecipitates from di¡erent sources (as
indicated) were subjected to in vitro kinase assays by the speci¢c
L(28^40) peptide substrate (histogram) and analyzed for the pres-
ence of GPR94 by Western blotting (inset). Experimental conditions
are detailed in Section 2. Fig. 5. Phosphorylation of GRP94 by G-CK and CK2. The autora-
diography after SDS^PAGE is shown in A. The molecular weight
markers (kDa) are indicated on the left side. In B, the GRP94 ra-
diolabeled bands detected in lanes 3 (a) and 5 (b) of A were blotted
to nitrocellulose, excised and eluted by tryptic digestion, followed
by 6 N HCl hydrolysis as described in Section 2. 32P-serine and
32P-threonine were isolated by high-voltage paper electrophoresis at
pH 1.9 (see Section 2) and detected by autoradiography.
Table 1
Kinetic constants for the phosphorylation of GRP94-derived synthetic peptides by G-CK
Nomenclature Sequence G-CK
Km (mM) Vmax (nmol/min/mg) Vmax/Km
GRP94 (12^24) EDLGKS17REGARAP 0.220 0.37 1.6
GRP94 (320^333) KWQRPS326KEVEEDE 0.125 2.97 23.7
GRP94 (337^349) KYKAFS346KEADDPM 1.659 18.60 11.2
GRP94 (420^433) KPLNVS426RETLQQH 1.659 15.00 9.0
GRP94 (580^593) KKTKES586REATEKE 0.086 3.3 38.2
Experimental conditions are described in Section 2 with the exception that peptide concentrations were varied. Values are means of at least
three determinations with a standard error less than 15%. Phosphorylatable serines are numbered according to dog GRP94. Underlining de-
notes the glutamic acid supposed to act as speci¢city determinant.
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others pepsin, ¢brinogen, ACTH, progastrin, furin, osteopon-
tin, matrix Gla protein, mannose-6-P receptor (see [13,14] and
references therein), only a in few cases, their actual phosphor-
ylation by G-CK has been documented, namely with osteo-
pontin [15] and the salivary APRP [26].
Here, we show that another bona ¢de substrate of G-CK is
the Ca2 binding GRP94, also termed endoplasmin. This pro-
tein belongs to the stress protein family, whose synthesis is
enhanced when extracellular glucose is low, intracellular Ca2
stores are depleted or glycosylation is inhibited [27]. GRP94 is
50% homologous to 90 kDa heat shock protein (HSP90).
Both GRP94 and HSP90 have been reported to undergo sig-
ni¢cant autophosphorylation [25,28] as well as phosphory-
lation by protein kinase CK2 [24,29]. In our hands, no auto-
phosphorylation of GRP94 could be detected using a highly
puri¢ed preparation from rat liver microsomes entirely free of
casein kinase activity (Section 2.6); the same preparation is
readily phosphorylated by either CK2 or G-CK at residues
which are partially if not entirely di¡erent. Based on our data,
the ¢rst choice candidates for undergoing phosphorylation by
G-CK are sites displaying the sequence S-R/K-E, a motif
which is also found in HSP90 and which is refractory to
CK2 phosphorylation. It would be interesting to check
whether other proteins containing this motif are also suscep-
tible to G-CK phosphorylation.
The physiological relevance of G-CK-catalyzed GRP94
phosphorylation is strongly supported by its low Km value
(0.2 WM) and by the ¢nding that the two proteins interact
with each other, being co-immunoprecipitated from extracts
of lactating mammary gland Golgi apparatus and undergoing
co-elution during several steps of the G-CK puri¢cation pro-
cedure. The detection of substantial amounts of Golgi-associ-
ated GRP94 was rather unexpected considering the major
localization of this protein to the ER fraction, by virtue of
its C-terminal ER retention KDEL motif. The possibility that
our ¢nding might be accounted for by contaminations from
ER membranes is hardly conceivable, considering the high
degree of puri¢cation of the Golgi preparation used in this
study as judged from its lack of detectable activity of marker
enzymes of particulate fractions other than the Golgi appara-
tus itself (see Section 2.2). On the other hand, the detection of
GRP94 exported from the ER to other subcellular fractions,
including the Golgi apparatus, has already been reported (e.g.
[30^32]). In this respect, it is tempting to speculate that bind-
ing to G-CK is the driving force contributing to the Golgi
localization of GRP94. Pertinent to this might also be the
observation that lactating mammary gland is the tissue where
by far the highest expression of G-CK has been found [13]. It
would be interesting therefore to check in di¡erent tissues
whether there is a correlation between G-CK expression and
Golgi localization of GRP94. The molecular features of the
interaction between G-CK and GRP94 are presently un-
known. Considering however that GRP94 tends to dimerize
[33] and that the apparent Mr of G-CK/GRP94 complex
eluted from Superdex 200 approximates 400 kDa, it seems
likely that one GRP94 dimer binds to one G-CK molecule,
assuming for this latter a Mr around 170 kDa (see Fig. 2). At
present, it is not clear whether the formation of these supra-
molecular complexes is a mere consequence of enzyme^sub-
strate interaction or it re£ects more complicated functional
relationships between GRP94 and G-CK. However, the
much higher a⁄nity for G-CK of full size GRP94 as com-
pared to its phosphoacceptor peptides, as judged from three
orders of magnitude lower Km values, would be more consis-
tent with the latter hypothesis.
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